421 related articles for article (PubMed ID: 15720454)
1. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations.
Swan H; Laitinen P; Kontula K; Toivonen L
J Cardiovasc Electrophysiol; 2005 Feb; 16(2):162-6. PubMed ID: 15720454
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.
Haugaa KH; Leren IS; Berge KE; Bathen J; Loennechen JP; Anfinsen OG; Früh A; Edvardsen T; Kongsgård E; Leren TP; Amlie JP
Europace; 2010 Mar; 12(3):417-23. PubMed ID: 20106799
[TBL] [Abstract][Full Text] [Related]
3. Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves.
Paavola J; Viitasalo M; Laitinen-Forsblom PJ; Pasternack M; Swan H; Tikkanen I; Toivonen L; Kontula K; Laine M
Eur Heart J; 2007 May; 28(9):1135-42. PubMed ID: 17347175
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia.
Marks AR; Priori S; Memmi M; Kontula K; Laitinen PJ
J Cell Physiol; 2002 Jan; 190(1):1-6. PubMed ID: 11807805
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of abnormal calcium homeostasis in mutations responsible for catecholaminergic polymorphic ventricular tachycardia.
Iyer V; Hajjar RJ; Armoundas AA
Circ Res; 2007 Feb; 100(2):e22-31. PubMed ID: 17234962
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
Rosso R; Kalman JM; Rogowski O; Diamant S; Birger A; Biner S; Belhassen B; Viskin S
Heart Rhythm; 2007 Sep; 4(9):1149-54. PubMed ID: 17765612
[TBL] [Abstract][Full Text] [Related]
7. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.
Kontula K; Laitinen PJ; Lehtonen A; Toivonen L; Viitasalo M; Swan H
Cardiovasc Res; 2005 Aug; 67(3):379-87. PubMed ID: 15913575
[TBL] [Abstract][Full Text] [Related]
8. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.
Postma AV; Denjoy I; Kamblock J; Alders M; Lupoglazoff JM; Vaksmann G; Dubosq-Bidot L; Sebillon P; Mannens MM; Guicheney P; Wilde AA
J Med Genet; 2005 Nov; 42(11):863-70. PubMed ID: 16272262
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia.
Aizawa Y; Ueda K; Komura S; Washizuka T; Chinushi M; Inagaki N; Matsumoto Y; Hayashi T; Takahashi M; Nakano N; Yasunami M; Kimura A; Hiraoka M; Aizawa Y
Int J Cardiol; 2005 Mar; 99(2):343-5. PubMed ID: 15749201
[TBL] [Abstract][Full Text] [Related]
10. Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies.
George CH; Jundi H; Thomas NL; Fry DL; Lai FA
J Mol Cell Cardiol; 2007 Jan; 42(1):34-50. PubMed ID: 17081562
[TBL] [Abstract][Full Text] [Related]
11. Exercise-induced polymorphic ventricular tachycardia in adults without structural heart disease.
Tan JH; Scheinman MM
Am J Cardiol; 2008 Apr; 101(8):1142-6. PubMed ID: 18394448
[TBL] [Abstract][Full Text] [Related]
12. Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation.
Allouis M; Probst V; Jaafar P; Schott JJ; Le Marec H
Am J Cardiol; 2005 Mar; 95(5):700-2. PubMed ID: 15721128
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics of exercise-induced polymorphic ventricular tachycardia: identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms.
Laitinen PJ; Swan H; Kontula K
Eur J Hum Genet; 2003 Nov; 11(11):888-91. PubMed ID: 14571276
[TBL] [Abstract][Full Text] [Related]
14. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.
George CH; Higgs GV; Lai FA
Circ Res; 2003 Sep; 93(6):531-40. PubMed ID: 12919952
[TBL] [Abstract][Full Text] [Related]
15. Catecholaminergic polymorphic ventricular tachycardia caused by a novel mutation in the cardiac ryanodine receptor.
Hasdemir C; Aydin HH; Sahin S; Wollnik B
Anadolu Kardiyol Derg; 2008 Oct; 8(5):E35-6. PubMed ID: 18849218
[No Abstract] [Full Text] [Related]
16. Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.
van der Werf C; Nederend I; Hofman N; van Geloven N; Ebink C; Frohn-Mulder IM; Alings AM; Bosker HA; Bracke FA; van den Heuvel F; Waalewijn RA; Bikker H; van Tintelen JP; Bhuiyan ZA; van den Berg MP; Wilde AA
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):748-56. PubMed ID: 22787013
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.
Hayashi M; Denjoy I; Extramiana F; Maltret A; Buisson NR; Lupoglazoff JM; Klug D; Hayashi M; Takatsuki S; Villain E; Kamblock J; Messali A; Guicheney P; Lunardi J; Leenhardt A
Circulation; 2009 May; 119(18):2426-34. PubMed ID: 19398665
[TBL] [Abstract][Full Text] [Related]
18. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond.
Katz G; Arad M; Eldar M
Curr Probl Cardiol; 2009 Jan; 34(1):9-43. PubMed ID: 19068246
[TBL] [Abstract][Full Text] [Related]
19. Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death.
Jiang D; Wang R; Xiao B; Kong H; Hunt DJ; Choi P; Zhang L; Chen SR
Circ Res; 2005 Nov; 97(11):1173-81. PubMed ID: 16239587
[TBL] [Abstract][Full Text] [Related]
20. Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.
Alcalai R; Wakimoto H; Arad M; Planer D; Konno T; Wang L; Seidman JG; Seidman CE; Berul CI
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):316-24. PubMed ID: 20807279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
